Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|December 13, 2018
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 AminopeptidasesNatalie B Vinh, Nyssa Drinkwater, Tess R Malcolm, et al.Cell Reports|August 2, 2016
TAILS N-Terminomics and Proteomics Show Protein Degradation Dominates over Proteolytic Processing by Cathepsins in Pancreatic TumorsAnna Prudova, Vasilena Gocheva, Ulrich Auf dem Keller, et al.Journal of Medicinal Chemistry|June 29, 2019
Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding InteractionsJisook Lee, Natalie B Vinh, Nyssa Drinkwater, et al.Cell Reports|October 15, 2014
Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritisCaroline L Bellac, Antoine Dufour, Michael J Krisinger, et al.Cell Reports|December 14, 2024
SARS-CoV-2 3CL<sup>pro</sup> (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CL<sup>pro</sup>Peter M Grin, Kaushal Baid, Hugo C R de Jesus, et al.Matrix Biology : Journal of the International Society for Matrix Biology|September 27, 2015
Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analysesUlrich Eckhard, Pitter F Huesgen, Oliver Schilling, et al.Data in Brief|March 17, 2016
Active site specificity profiling datasets of matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and 14Ulrich Eckhard, Pitter F Huesgen, Oliver Schilling, et al.Cell Reports|October 21, 2021
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL<sup>pro</sup> substrate degradomeIsabel Pablos, Yoan Machado, Hugo C Ramos de Jesus, et al.Nature Medicine|May 3, 2014
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunityDavid J Marchant, Caroline L Bellac, Theo J Moraes, et al.Pageof 4